"Thanks Ken. Once again you have provided great information. From what I have read, RITUXAN infusion may be in the plan, but without determining chromosome 17p and p53 defective tumor suppressor, RITUXAN will not attach to the CD20 B-CE..."
Are you sure you want to delete your ?
You will no longer be able to add new data to this tracker.